Charles F. Wagner Jr., EVP & Chief Financial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 343 shares at $261.15 ($89K) on 2022-05-02, disclosed to the SEC on 2022-05-04.
Scheduled sale ($89k) by EVP & Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $254.87 | 20 | $5K | 5.7% |
| 2 | $257.18 | 100 | $26K | 29.0% |
| 3 | $258.21 | 60 | $15K | 17.5% |
| 4 | $259.45 | 80 | $21K | 23.4% |
| 5 | $261.15 | 48 | $13K | 14.1% |
| 6 | $262.06 | 32 |
| $8K |
| 9.4% |
| 7 | $264.37 | 3 | $793 | 0.9% |
| Total | $258.83 avg | 343 | $89K | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-11-13 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-06-05 | $1.5M | — | Filing → |